In accordance, ANXA2 is upregulated in astrocytes surrounding senile plaques and degenerating neurons in patients affected by AD and ANXA2 has been found to be one of the major components of synaptosomes obtained from AD patients and from mice overexpressing the P301S pathological form of Tau [119, 120]. Here, MAPT is linked to Alzheimer disease.